Nimotuzumab相关论文
Retrospective study comparing anti-EGFR monoclonal antibody plus cisplatin-based chemoradiotherapy v
...
A phase Ⅱ study of concurrent nimotuzumab and intensitymodulated radiotherapy in elderly patients wi
...
EGFR-targeting antibodies enhance the irradiation response of esophageal cancer cell lines of differ
There is an established relationship between epidermal growth factor receptor (EGFR) expression and tumor cell prolifera......
Effects of nimotuzumab in combination with paclitaxel in human highly metastatic ovarian carcinoma c
目的： This study was to investigate the effects of nimotuzumab combined paclitaxel against human highly metastatic ovaria......
Purpose: To evaluate the feasibility of adding nimotuzumab to concurrent paclitaxel/cisplatin(TP) regimen and intensity-......
Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients:A phaseⅡclinical trial
Objective:To investigate the safety and efficacy of nimotuzumab combined with radiotherapy for elderly patients with non......
目的探讨尼妥珠单抗联合同步放化疗治疗局部晚期食管癌患者的临床疗效。方法选择局部晚期食管癌患者80例为研究对象，按照随机数字表......
目的观察尼妥珠单抗联合调强适形放疗(IMRT)治疗晚期局部鼻咽癌临床疗效及预后。方法选取42例晚期鼻咽癌患者，采用随机数字表法分为......
A phase Ⅰ study of nimotuzumab plus docetaxel in chemotherapy-refractory/resistant patients with adv
...
Radiotherapy combined with nimotuzumab for elderly esophageal cancer patients: A phase Ⅱ clinical tr
Objective: To investigate the safety and efficacy of nimotuzumab combined with radiotherapy for elderly patients with no......
目的探讨尼妥珠单抗(h-R3)对体外人食管鳞癌KYSE30细胞株的放射增敏效应。方法采用培养的人食管鳞癌KYSE30细胞株行体外放射实验,......
Effect of nimotuzumab targeted therapy combined with conventional chemotherapy in treatment of advan
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7......
目的 探讨尼妥珠单抗联合同步放化疗治疗局部晚期食管癌患者的近期疗效.方法 回顾性选择山东省日照市人民医院2012年1月至2013年1......
目的探讨尼妥珠单抗与同步放化疗联合治疗局部晚期头颈部恶性肿瘤的近期疗效和不良反应。方法以根治性同步放化疗同时给予尼妥珠单......
Specific Immunotherapy in Advanced Cervical-Uterine Cancer Using Humanized Monoclonal Antibody Nimot
Cervical uterine cancer represents the fourth most common malignant neoplasm worldwide in the female sex in terms of inc......
目的探讨尼妥珠单抗联合盐酸吉西他滨治疗高表达表皮生长因子受体(EGFR)胰腺癌患者的临床疗效和毒副反应。方法选取2017年8月至202......
目的探讨尼妥珠单抗联合放化疗治疗局部区域晚期鼻咽癌的的近期疗效及不良反应。方法选取2015年4月~2017年12月收治的Ⅲ~Ⅳa期鼻咽......
目的分子靶向治疗是目前肺腺癌治疗的热点,靶向于表皮生长因子受体（epidermal growth factor receptor,EGFR）的单抗可提高化疗效果,......
目的研究尼妥珠单抗(h-R3)和西托昔单抗(C225)对食管癌患者放射增敏作用的影响。方法体外培养人食管癌细胞株TE-13,分为对照组(单......
目的：分析食管癌放疗后复发患者应用尼妥珠单抗联合放疗的价值。方法：2012年1月至2013年12月符合纳入标准的食管癌放疗后复发患者28......
大量研究表明，EGFR信号通路与放疗抵抗相关，许多恶性肿瘤高度表达EGFR。 EGFR阻断成为放疗增敏的途径之一。作为第一个由中国和古巴......
目的：观察尼妥珠单抗联合放疗并同期化疗治疗局部晚期食管癌患者的临床副反应，探讨有效的针对性护理方法。方法：52例经病理证实的晚期......
目的：探讨尼妥珠单抗联合奈达铂同步放化疗治疗局部晚期食管癌的临床效果。方法：选取局部晚期食管癌患者64例,随机分为观察组和对照......
目的探索尼妥珠单抗联合多西他赛和顺铂治疗中晚期鼻咽癌的有效性和安全性。方法入组46例经病理学确诊的中晚期鼻咽癌患者分为对照......
目的研究在局部晚期鼻咽癌的治疗中联合使用尼妥珠单抗和卡培他滨片的临床效果。方法 50例晚期鼻咽癌患者,随机分为观察组和对照组......
目的：观察尼妥株单抗联合化疗治疗晚期胃癌的疗效及毒副反应.方法：采用尼妥株单抗联合传统化疗药物治疗13例晚期胃癌患者,尼妥株单抗......
目的：探讨尼妥珠单抗联合同期三维适形放疗（3D-CRT）及化疗治疗Ⅲ、ⅣA期鼻咽癌的疗效及不良反应.方法：经组织病理确诊的Ⅲ、ⅣA期（2008......
目的尼妥珠单抗（Nimotuzumab）简称hR3,是表皮生长因子单克隆抗体,对多种实体瘤细胞具有明显的放疗增敏作用,四氧化三铁纳米粒子有良......
目的观察尼妥珠单抗联合放化疗治疗局部晚期宫颈癌的疗效及不良反应。方法将72例Ⅱb～Ⅳa期宫颈癌患者随机分为2组。对照组采用调强......
目的 观察尼妥珠单抗联合三维适形放疗对复发性鼻咽癌的疗效和不良反应.方法 32例符合入选标准的复发性鼻咽癌患者按照随机的方法......
目的：了解我院尼妥珠单抗的临床应用现状、疗效及不良反应。方法：收集我院2009年2月-2010年2月107例应用尼妥珠单抗患者的临床资料,......
目的探讨尼妥珠单抗联合奈达铂和三维适形同步放化疗对鼻咽癌的疗效、安全性及对TGF-β1、S100A8和S100A9的影响。方法选取2009年4......
目的观察尼妥珠单抗联合多西他赛-顺铂-氟尿嘧啶（DCF）治疗晚期口腔癌的短期疗效及不良反应。方法 9例晚期口腔癌患者采用尼妥珠单抗......
目的观察尼妥珠单抗治疗晚期肺鳞癌的临床疗效和安全性。方法回顾性分析12例使用尼妥珠单抗治疗肺鳞癌患者的临床资料，并进行疗效和......
A 50-year male patient presented to outpatient department with a mass on tongue associated with pain. A plain computeris......
目的：结合国内实际情况，探索靶向综合治疗晚期口腔颌面-头颈鳞癌，旨在明确其疗效，提高患者的近期生存率。方法：2008年4月-2010年4月综合......
目的评价放疗联合尼妥珠单抗治疗中老年局部晚期复发直肠癌的效果。方法选100例局部晚期复发直肠癌患者,分为观察组和对照组各50例......
背景与目的表皮生长因子受体（epidermal growth factor receptor,EGFR）过表达在肺鳞癌中常见,而与预后差相关。本研究旨在观察抗EGFR......
由中华医学会外科分会腹腔镜与内镜学组、中国抗癌协会大肠癌专业委员会腹腔镜外科学组、中国中西医结合大肠肛门病专业委员会、中......
目的观察尼妥珠单抗联合三维适形和顺铂同步放化疗治疗鼻咽癌的疗效及其毒副作用。方法对照组24例采用三维适形放疗和顺铂方案同步......
Preclinical Efficacy of Nimotuzumab, an Anti-Egfr Monoclonal Antibody as a Single Agent Therapy in H
Background: The poor prognosis of patients with high-grade glioma multiform (GBM) has led investigators to the search of......
Concurrent Nimotuzumab with Radiation Therapy in Locally Advanced Cancers of Oropharynx and Hypophar
Background: The prevalence of head and neck cancers in the world is around 57% and predominantly occurs in Asian countri......
Nimotuzumab with Concurrent Chemo-Radiotherapy in Patients with Locally Advanced Squamous Cell Carci
Background: Head and neck cancers (HNCs) constitute 5% of all cancers globally and are the most common cancers in India.......
Background: Head and neck squamous cell carcinoma (HNSCC), is a common malignancy in the Indian Population. In locally a......
Brainstem glioma is rare tumour in adults accounting for 1% - 2% of intracranial gliomas. In this case study, a 28-year-......
目的回顾性分析尼妥珠单抗治疗晚期非小细胞肺癌（NSCLC）的临床疗效及不良反应。方法纳入15例经病理组织学或细胞学检查确诊的Ⅳ期NSC......
目的:对我院3种新型抗肿瘤靶向抗体药物尼妥珠单抗(nimotuzumab)、西妥昔单抗(cetux-imab)及利妥昔单抗(rituximab)进行临床应用状......
Assessment of the serum tumor markers and lesion cancer cell proliferation after Nimotuzumab combine
Objective:To study the change of serum tumor markers and lesion cancer cell proliferation gene expression after Nimotuzu......
